Effect of Strength Training and Protein Supplementation on Muscles in the Very-old
NCT ID: NCT01997320
Last Updated: 2015-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2013-11-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary hypothesis is that the group conducting exercise improves muscle size, structure and function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Protein and Resistance Exercise in Elderly
NCT04023513
Effect of Low Intensity Exercise and Protein Intake on Skeletal Muscle Protein Synthesis in Elderly
NCT01640145
The Effect of Strength Training and Protein Supplementation in Old Pre-frail Individuals
NCT03723902
Effect of Strength Training and Protein Ingestion in Old Versus Very-old
NCT02105922
The Importance of Additional Protein to Benefit More From Training During and After Hospitalization
NCT02717819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group one (n=15) is the exercise and nutrition group (HRT). Subjects in this group are to conduct supervised center-based heavy resistance exercise of the lower extremities three times weekly for 12 weeks. As for group two, this group receives nutritional supplementation twice daily throughout the 12 weeks period. Supplementation contains 20g of milk protein and some carbohydrate and lipids.
Group two (n=15) is the nutrition group (PRO). Subjects in this group only receives nutritional supplementation as described above.
After 12 weeks of intervention the same strength- and functional measures are made, DXA- and MR-scans and a second biopsy is made along with tendon stiffness measurement.
Data is collected and analyzed by staff blinded to randomization. Personal data is locked up, and only anonymized data is analyzed. Differences in both primary (m. quadriceps femoris cross sectional area) and secondary outcomes (functional measures, strength measures, muscle cell- and fiber type count, mRNA expression, muscle collagen content and distribution) are evaluated using two-way anova with repeated measures and, if allowed, post-hoc tests. Analysis will be made as intention-to-treat.
Power:
With an expected 10% increase in quadriceps CSA (cross-sectional area) (from 4500 square mm at baseline) with a SD of 600 square mm, power is 82% with alfa 0.05 with inclusion of 15 subjects in each group.
In case of systematic health-issues in response to the intervention, the trial will end immediately.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heavy resistance exercise and nutrition
Heavy resistance exercise of the lower extremities three times weekly for 12 weeks combined with nutrient supplementation twice daily each containing 20g of milk protein.
Heavy resistance exercise and nutrition
Heavy resistance exercise of the lower extremities three times weekly for 12 weeks.
Nutrition supplement
Nutrient supplementation twice daily for 12 weeks. Each supplement contains 20g of milk protein.
Nutrition supplement
Two daily administrations of nutrient supplementation, each containing 20g of milk protein.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heavy resistance exercise and nutrition
Heavy resistance exercise of the lower extremities three times weekly for 12 weeks.
Nutrition supplement
Two daily administrations of nutrient supplementation, each containing 20g of milk protein.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unstable chronic diseases, eg. renal failure, uncontrolled cardiac arrythmias, severe COPD (Chronic Obstructive Pulmonary Disease), diabetes mellitus.
* Bilateral knee alloplastics
* Metal devices compromising MR-scanning.
* Medicine: Anticoagulants (K-vitamin antagonists, heparins, ADP-receptor blockers, direct thrombin inhibitors, factor Xa inhibitors), systemic steroid treatment.
* Dementia
* Regular heavy load resistance exercise more than 20 min/week.
83 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rasmus Leidersdorff Bechshøft
M.D., Ph.d. student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Kjaer, MD, Proff.
Role: STUDY_CHAIR
Head of department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Sports Medicine Copenhagen, Bispbebjerg Hospital
Copenhagen NV, Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-4-2013-068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.